世界のDNAワクチン接種市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global DNA Vaccination Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12226 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、DNAワクチン接種のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。DNAワクチン接種の種類別市場規模（ヒトDNAワクチン、動物DNAワクチン）、用途別市場規模（病院、研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・DNAワクチン接種の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Inovio Pharmaceuticals、Merck、Astellas Pharma、Pfizer ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ヒトDNAワクチン、動物DNAワクチン ・用途別分析2016年-2026年：病院、研究所、その他 ・DNAワクチン接種の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・DNAワクチン接種のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・DNAワクチン接種のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・DNAワクチン接種の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・DNAワクチン接種の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The DNA Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global DNA Vaccination size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global DNA Vaccination market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
DNA Vaccination market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Human DNA Vaccines
Animal DNA Vaccines

Market segment by Application, can be divided into
Hospitals
Research and Academic Laboratories
Others

Market segment by players, this report covers
Inovio Pharmaceuticals
Merck
Astellas Pharma
Pfizer

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of DNA Vaccination
1.2 Classification of DNA Vaccination by Type
1.2.1 Overview: Global DNA Vaccination Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global DNA Vaccination Revenue Market Share by Type in 2020
1.2.3 Human DNA Vaccines
1.2.4 Animal DNA Vaccines
1.3 Global DNA Vaccination Market by Application
1.3.1 Overview: Global DNA Vaccination Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Research and Academic Laboratories
1.3.4 Others
1.4 Global DNA Vaccination Market Size & Forecast
1.5 Global DNA Vaccination Market Size and Forecast by Region
1.5.1 Global DNA Vaccination Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global DNA Vaccination Market Size by Region, (2016-2021)
1.5.3 North America DNA Vaccination Market Size and Prospect (2016-2026)
1.5.4 Europe DNA Vaccination Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific DNA Vaccination Market Size and Prospect (2016-2026)
1.5.6 South America DNA Vaccination Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa DNA Vaccination Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 DNA Vaccination Market Drivers
1.6.2 DNA Vaccination Market Restraints
1.6.3 DNA Vaccination Trends Analysis
2 Company Profiles
2.1 Inovio Pharmaceuticals
2.1.1 Inovio Pharmaceuticals Details
2.1.2 Inovio Pharmaceuticals Major Business
2.1.3 Inovio Pharmaceuticals DNA Vaccination Product and Solutions
2.1.4 Inovio Pharmaceuticals DNA Vaccination Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Inovio Pharmaceuticals Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck DNA Vaccination Product and Solutions
2.2.4 Merck DNA Vaccination Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Merck Recent Developments and Future Plans
2.3 Astellas Pharma
2.3.1 Astellas Pharma Details
2.3.2 Astellas Pharma Major Business
2.3.3 Astellas Pharma DNA Vaccination Product and Solutions
2.3.4 Astellas Pharma DNA Vaccination Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Astellas Pharma Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer DNA Vaccination Product and Solutions
2.4.4 Pfizer DNA Vaccination Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pfizer Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global DNA Vaccination Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 DNA Vaccination Players Market Share
3.2.2 Top 10 DNA Vaccination Players Market Share
3.2.3 Market Competition Trend
3.3 DNA Vaccination Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global DNA Vaccination Revenue and Market Share by Type (2016-2021)
4.2 Global DNA Vaccination Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global DNA Vaccination Revenue Market Share by Application (2016-2021)
5.2 DNA Vaccination Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America DNA Vaccination Revenue by Type (2016-2026)
6.2 North America DNA Vaccination Revenue by Application (2016-2026)
6.3 North America DNA Vaccination Market Size by Country
6.3.1 North America DNA Vaccination Revenue by Country (2016-2026)
6.3.2 United States DNA Vaccination Market Size and Forecast (2016-2026)
6.3.3 Canada DNA Vaccination Market Size and Forecast (2016-2026)
6.3.4 Mexico DNA Vaccination Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe DNA Vaccination Revenue by Type (2016-2026)
7.2 Europe DNA Vaccination Revenue by Application (2016-2026)
7.3 Europe DNA Vaccination Market Size by Country
7.3.1 Europe DNA Vaccination Revenue by Country (2016-2026)
7.3.2 Germany DNA Vaccination Market Size and Forecast (2016-2026)
7.3.3 France DNA Vaccination Market Size and Forecast (2016-2026)
7.3.4 United Kingdom DNA Vaccination Market Size and Forecast (2016-2026)
7.3.5 Russia DNA Vaccination Market Size and Forecast (2016-2026)
7.3.6 Italy DNA Vaccination Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific DNA Vaccination Revenue by Type (2016-2026)
8.2 Asia-Pacific DNA Vaccination Revenue by Application (2016-2026)
8.3 Asia-Pacific DNA Vaccination Market Size by Region
8.3.1 Asia-Pacific DNA Vaccination Revenue by Region (2016-2026)
8.3.2 China DNA Vaccination Market Size and Forecast (2016-2026)
8.3.3 Japan DNA Vaccination Market Size and Forecast (2016-2026)
8.3.4 South Korea DNA Vaccination Market Size and Forecast (2016-2026)
8.3.5 India DNA Vaccination Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia DNA Vaccination Market Size and Forecast (2016-2026)
8.3.7 Australia DNA Vaccination Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America DNA Vaccination Revenue by Type (2016-2026)
9.2 South America DNA Vaccination Revenue by Application (2016-2026)
9.3 South America DNA Vaccination Market Size by Country
9.3.1 South America DNA Vaccination Revenue by Country (2016-2026)
9.3.2 Brazil DNA Vaccination Market Size and Forecast (2016-2026)
9.3.3 Argentina DNA Vaccination Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa DNA Vaccination Revenue by Type (2016-2026)
10.2 Middle East & Africa DNA Vaccination Revenue by Application (2016-2026)
10.3 Middle East & Africa DNA Vaccination Market Size by Country
10.3.1 Middle East & Africa DNA Vaccination Revenue by Country (2016-2026)
10.3.2 Turkey DNA Vaccination Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia DNA Vaccination Market Size and Forecast (2016-2026)
10.3.4 UAE DNA Vaccination Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global DNA Vaccination Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global DNA Vaccination Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market DNA Vaccination Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global DNA Vaccination Revenue (USD Million) by Region (2016-2021)
Table 5. Global DNA Vaccination Revenue Market Share by Region (2021-2026)
Table 6. Inovio Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 7. Inovio Pharmaceuticals Major Business
Table 8. Inovio Pharmaceuticals DNA Vaccination Product and Solutions
Table 9. Inovio Pharmaceuticals DNA Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck DNA Vaccination Product and Solutions
Table 13. Merck DNA Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 15. Astellas Pharma Major Business
Table 16. Astellas Pharma DNA Vaccination Product and Solutions
Table 17. Astellas Pharma DNA Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Pfizer Corporate Information, Head Office, and Major Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer DNA Vaccination Product and Solutions
Table 21. Pfizer DNA Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Global DNA Vaccination Revenue (USD Million) by Players (2019-2021)
Table 23. Global DNA Vaccination Revenue Share by Players (2019-2021)
Table 24. Breakdown of DNA Vaccination by Company Type (Tier 1, Tier 2 and Tier 3)
Table 25. DNA Vaccination Players Head Office, Products and Services Provided
Table 26. DNA Vaccination Mergers & Acquisitions in the Past Five Years
Table 27. DNA Vaccination New Entrants and Expansion Plans
Table 28. Global DNA Vaccination Revenue (USD Million) by Type (2016-2021)
Table 29. Global DNA Vaccination Revenue Share by Type (2016-2021)
Table 30. Global DNA Vaccination Revenue Forecast by Type (2021-2026)
Table 31. Global DNA Vaccination Revenue by Application (2016-2021)
Table 32. Global DNA Vaccination Revenue Forecast by Application (2021-2026)
Table 33. North America DNA Vaccination Revenue by Type (2016-2021) & (USD Million)
Table 34. North America DNA Vaccination Revenue by Type (2021-2026) & (USD Million)
Table 35. North America DNA Vaccination Revenue by Application (2016-2021) & (USD Million)
Table 36. North America DNA Vaccination Revenue by Application (2021-2026) & (USD Million)
Table 37. North America DNA Vaccination Revenue by Country (2016-2021) & (USD Million)
Table 38. North America DNA Vaccination Revenue by Country (2021-2026) & (USD Million)
Table 39. Europe DNA Vaccination Revenue by Type (2016-2021) & (USD Million)
Table 40. Europe DNA Vaccination Revenue by Type (2021-2026) & (USD Million)
Table 41. Europe DNA Vaccination Revenue by Application (2016-2021) & (USD Million)
Table 42. Europe DNA Vaccination Revenue by Application (2021-2026) & (USD Million)
Table 43. Europe DNA Vaccination Revenue by Country (2016-2021) & (USD Million)
Table 44. Europe DNA Vaccination Revenue by Country (2021-2026) & (USD Million)
Table 45. Asia-Pacific DNA Vaccination Revenue by Type (2016-2021) & (USD Million)
Table 46. Asia-Pacific DNA Vaccination Revenue by Type (2021-2026) & (USD Million)
Table 47. Asia-Pacific DNA Vaccination Revenue by Application (2016-2021) & (USD Million)
Table 48. Asia-Pacific DNA Vaccination Revenue by Application (2021-2026) & (USD Million)
Table 49. Asia-Pacific DNA Vaccination Revenue by Region (2016-2021) & (USD Million)
Table 50. Asia-Pacific DNA Vaccination Revenue by Region (2021-2026) & (USD Million)
Table 51. South America DNA Vaccination Revenue by Type (2016-2021) & (USD Million)
Table 52. South America DNA Vaccination Revenue by Type (2021-2026) & (USD Million)
Table 53. South America DNA Vaccination Revenue by Application (2016-2021) & (USD Million)
Table 54. South America DNA Vaccination Revenue by Application (2021-2026) & (USD Million)
Table 55. South America DNA Vaccination Revenue by Country (2016-2021) & (USD Million)
Table 56. South America DNA Vaccination Revenue by Country (2021-2026) & (USD Million)
Table 57. Middle East & Africa DNA Vaccination Revenue by Type (2016-2021) & (USD Million)
Table 58. Middle East & Africa DNA Vaccination Revenue by Type (2021-2026) & (USD Million)
Table 59. Middle East & Africa DNA Vaccination Revenue by Application (2016-2021) & (USD Million)
Table 60. Middle East & Africa DNA Vaccination Revenue by Application (2021-2026) & (USD Million)
Table 61. Middle East & Africa DNA Vaccination Revenue by Country (2016-2021) & (USD Million)
Table 62. Middle East & Africa DNA Vaccination Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. DNA Vaccination Picture
Figure 2. Global DNA Vaccination Revenue Market Share by Type in 2020
Figure 3. Human DNA Vaccines
Figure 4. Animal DNA Vaccines
Figure 5. DNA Vaccination Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Research and Academic Laboratories Picture
Figure 8. Others Picture
Figure 9. Global DNA Vaccination Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global DNA Vaccination Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global DNA Vaccination Revenue Market Share by Region (2016-2026)
Figure 12. Global DNA Vaccination Revenue Market Share by Region in 2020
Figure 13. North America DNA Vaccination Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe DNA Vaccination Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific DNA Vaccination Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America DNA Vaccination Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa DNA Vaccination Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. DNA Vaccination Market Drivers
Figure 19. DNA Vaccination Market Restraints
Figure 20. DNA Vaccination Market Trends
Figure 21. Inovio Pharmaceuticals Recent Developments and Future Plans
Figure 22. Merck Recent Developments and Future Plans
Figure 23. Astellas Pharma Recent Developments and Future Plans
Figure 24. Pfizer Recent Developments and Future Plans
Figure 25. Global DNA Vaccination Revenue Share by Players in 2020
Figure 26. DNA Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 27. Global Top 3 Players DNA Vaccination Revenue Market Share in 2020
Figure 28. Global Top 10 Players DNA Vaccination Revenue Market Share in 2020
Figure 29. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 30. Global DNA Vaccination Revenue Share by Type in 2020
Figure 31. Global DNA Vaccination Market Share Forecast by Type (2021-2026)
Figure 32. Global DNA Vaccination Revenue Share by Application in 2020
Figure 33. Global DNA Vaccination Market Share Forecast by Application (2021-2026)
Figure 34. North America DNA Vaccination Sales Market Share by Type (2016-2026)
Figure 35. North America DNA Vaccination Sales Market Share by Application (2016-2026)
Figure 36. North America DNA Vaccination Revenue Market Share by Country (2016-2026)
Figure 37. United States DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 38. Canada DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Mexico DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Europe DNA Vaccination Sales Market Share by Type (2016-2026)
Figure 41. Europe DNA Vaccination Sales Market Share by Application (2016-2026)
Figure 42. Europe DNA Vaccination Revenue Market Share by Country (2016-2026)
Figure 43. Germany DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. France DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. United Kingdom DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Russia DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Italy DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Asia-Pacific DNA Vaccination Sales Market Share by Type (2016-2026)
Figure 49. Asia-Pacific DNA Vaccination Sales Market Share by Application (2016-2026)
Figure 50. Asia-Pacific DNA Vaccination Revenue Market Share by Region (2016-2026)
Figure 51. China DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Japan DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. South Korea DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. India DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Southeast Asia DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Australia DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South America DNA Vaccination Sales Market Share by Type (2016-2026)
Figure 58. South America DNA Vaccination Sales Market Share by Application (2016-2026)
Figure 59. South America DNA Vaccination Revenue Market Share by Country (2016-2026)
Figure 60. Brazil DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Argentina DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Middle East and Africa DNA Vaccination Sales Market Share by Type (2016-2026)
Figure 63. Middle East and Africa DNA Vaccination Sales Market Share by Application (2016-2026)
Figure 64. Middle East and Africa DNA Vaccination Revenue Market Share by Country (2016-2026)
Figure 65. Turkey DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Saudi Arabia DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. UAE DNA Vaccination Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Methodology
Figure 69. Research Process and Data Source

---